Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk (Q42263074)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2013

Language	Label	Description	Also known as
English	Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk	scientific article published on October 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Yifang Han

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Rui Pu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Xue Han

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jun Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Weiping Li

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jianhua Yin

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yuwei Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Qiuxia Shen

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jiaxin Xie

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Qi Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Shuang Jiang

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Juhong Li

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hongwei Zhang

13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hongyang Wang

14

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Guangwen Cao

15

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

728-736

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Resection and liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese population.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Clinical relevance and public health significance of hepatitis B virus genomic variations

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

HBV genotype C is independently associated with cirrhosis in community-based population

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12313

21 January 2018

Identifiers

10.1111/LIV.12313

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42263074&oldid=2102776094"